Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Rhea-AI Summary

Pfizer Inc. (NYSE: PFE) will host a webcast featuring its Inflammation & Immunology leadership team at the Barclays Global Healthcare Conference on March 15, 2022, at 10:45 a.m. EDT. Key speakers include Michael Gladstone, Michael Vincent, and Michael Corbo. Investors and the public can access the live discussion and subsequent replay on Pfizer's investor website. The discussion aims to cover key insights into Pfizer's strategies and product pipeline. A transcript will also be available within 24 hours, remaining accessible for 90 days.

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Pfizer’s Inflammation & Immunology leadership team – Michael Gladstone, Global President; Michael Vincent, SVP & Chief Scientific Officer; and Michael Corbo, SVP & Chief Development Officer – at the Barclays Global Healthcare Conference on Tuesday, March 15, 2022 at 10:45 a.m. Eastern Daylight Time.

To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.

The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.

About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans, strategy and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; and our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 and treatment for COVID-19, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Category: Financial

View source version on businesswire.com: https://www.businesswire.com/news/home/20220308005129/en/

Media Contact:

PfizerMediaRelations@Pfizer.com

+1 (212) 733-1226

Investor Contact:

IR@Pfizer.com

+1 (212) 733-4848

Source: Pfizer Inc.

FAQ

What is Pfizer's upcoming webcast about on March 15, 2022?

Pfizer's webcast on March 15, 2022, will feature its Inflammation & Immunology leadership discussing insights into the company's strategies and product pipeline.

Who are the speakers at the Pfizer webcast on March 15, 2022?

The speakers include Michael Gladstone, Global President; Michael Vincent, SVP & Chief Scientific Officer; and Michael Corbo, SVP & Chief Development Officer.

How can I access the Pfizer webcast on March 15, 2022?

You can access the Pfizer webcast by visiting their investor website at www.pfizer.com/investors.

When will the Pfizer webcast replay be available?

The replay of the Pfizer webcast will be available on their investor website within 24 hours after the live discussion.

How long will the Pfizer webcast replay be accessible?

The replay of the Pfizer webcast will be accessible for at least 90 days.